Endovascular Engineering, Inc. ("E2") proudly announced positive safety and feasibility results from its ENGULF US clinical trial as late-breaking science at the Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions and simultaneously published in JSCAI.

Following the regulatory victory of Balversa in urothelial carcinoma, Johnson & Johnson on Friday continued its bladder cancer winning streak with an 82.8% complete response rate forTAR-200 in high-risk non-muscle invasive bladder cancer.

Inari Medical, Inc. announced its management team will present at the upcoming Bank of America Securities Healthcare Conference on Wednesday, May 15, 2024, at 11:20 AM Pacific Time.

BIOLASE, Inc. announced that it will release first quarter 2024 financial and operating results on Monday, May 13, 2024, after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.

Scientia Vascular, a leader in neurovascular innovation, is thrilled to announce the FDA clearance of two uniquely engineered catheters: the Plato 17—a DMSO-compatible microcatheter—and the Socrates 38, an aspiration catheter engineered for ischemic stroke.

The latest product innovation by NICO Corporation is described as a "game-changing advancement" by neurosurgeons with early experience using the NICO Myriad SPECTRA System – the ONLY hand-held technology delivering blue excitation light to enhance tissue fluorescence and assist in the rapidly growing sector of fluorescence-guided surgical removal of...